Thomson Medical Group Ltd. · SGX:A50
Thomson Medical — FY2024 Earnings Presentation
20 slides from Thomson Medical's earnings presentation, Sep 11, 2024
Slide 1: Thomson Medical Group Limited FY2024 Results Briefing
Confidential THOMSON MEDICAL GROUP LIMITED FY2024 Results Briefing 11 September 2024
Slide 2: Disclaimer
Confidential Disclaimer ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OR ELSEWHERE. For the purposes of this disclaimer, this presentation (“Presentation”) shall mean and include the slides herei
Slide 3: Agenda
Confidential 1 Group Overview 2 FY2024 Financial Highlights 3 Key Operational Statistics 4 Future Growth Plans 3
Slide 4: Group Overview
1 Group Overview Confidential 4
Slide 5: Key Businesses
Confidential Key Businesses 100% ▪ One of the largest private providers of healthcare services for women and children in Singapore ▪ 37 clinics and centres today compared to 16 in 2010 S$200m FY24 Revenue ▪ Multi-disciplinary healthcare company listed on Bursa Malaysia ~70% ▪ Operates Thomson Hospit
Slide 6: Thomson Medical Pte Ltd (TMPL)
Confidential Thomson Medical Pte Ltd (“TMPL”) Singapore Hospital Operations & Ancillary Services 187 37 licensed beds(1) clinics & centres Established in 1979, TMPL owns and operates Thomson Medical Centre (“TMC”) and a network of specialist medical clinics and facilities providing outpatient women
Slide 7: TMC Life Sciences Berhad (TMCLS)
Confidential TMC Life Sciences Berhad (“TMCLS”) Malaysia Hospital Operations & Ancillary Services 373 licensed beds(1)(2) 5 fertility centres In 2008, TMCLS established Thomson Hospital Kota Damansara (“THKD”). THKD is its flagship multi-disciplinary tertiary care centre equipped with advanced medic
Slide 8: Far East Medical Vietnam Limited (FEMVN)
Confidential Far East Medical Vietnam Limited (“FEMVN”) Hospital Operations & Ancillary Services Vietnam In 2008, FEMVN established Franco-Vietnamese Hospital (“FV Hospital”). As the first JCI accredited hospital in South Vietnam, FV Hospital is known for its international standard of care, commitme
Slide 9: FY2024 Financial Highlights
2 FY2024 Financial Highlights Confidential 9
Slide 10: Group Financial Highlights – FY2024
Confidential Group Financial Highlights – FY2024 Profitability Financial Position Cash Flows 1.3% decrease in Revenue from Cash position of Interest expenses of $355.8m in FY2023 to $167.3m $51.6m $351.2m in FY2024 Net cash outflow of Debt of $1.1b 0.9% decrease in EBITDA from $125.3m $103.3m in FY2
Slide 11: Historical Financial Highlights
Confidential Historical Financial Highlights REVENUE ($mil) ADJUSTED EBITDA ($mil) YoY YoY 1.3% 3.1% 109.7 106.5 109.8 333.7 355.8 351.2 - 0.4 - 0.4 - 0.3 - 15.5 50.4 22.1 24.4 95.0 78.8 YoY 5.5% YoY 9.9 100.1 10.8% 24.5 96.3 YoY 87.1 YoY 254.6 260.4 23.2% 41.4% 200.3 51.1 (2.0) (2.7) FY
Slide 12: Financial Highlights (Proforma)
Confidential Financial Highlights (Proforma)(1) REVENUE ($mil) ADJUSTED EBITDA(2) ($mil) YoY YoY 14.2% 13.5% YoY YoY 1.3% 3.1% 406.3 0.4 355.8 351.2 0.4 105.5 120.9 0.4 50.4 106.5 109.8 95.0 - 24.4 YoY YoY 5.5% 22.1 10.8% 24.4 100.1 100.1 21.0 9.9 24.5 24.5 YoY 41.4% YoY 23.2% 87.1 2
Slide 13: Geographical Segments – FY2024 (Proforma)
Confidential Geographical Segments – FY2024 (Proforma)(1) (2) Revenue Adjusted EBITDA (S$ in millions) (S$ in millions) $0.4m -$2.7m $24.4m $0.4m $105.5m 26% -3% 20% $95.0m 21% 27% $22.1m FY2023 FY2024 FY2023 FY2024 $51.1m 42% $355.8m $406.3m 49% $106.5m $21.0m 17% $120.9m $200.3m 82% 73% 25% 21% $2
Slide 14: Key Operational Statistics
3 Key Operational Statistics Confidential 14
Slide 15: Key Operating Statistics
Confidential Key Operating Statistics FY2021 FY2022 FY2023 FY2024 LICENSED BEDS1 Singapore 187 187 187 187 Malaysia 205 308 350 373 Vietnam4 - - - 230 Total 392 495 537 790 OPERATIONAL BEDS2 Singapore 181 181 178 178 Malaysia 170 299 314 341 Vietnam4 - - - 198 Total 351 480 492 717 BOR3 Singapore 55
Slide 16: Key Operating Statistics
Confidential Key Operating Statistics FY2021 FY2022 FY2023 FY2024 NUMBER OF INPATIENT Singapore 20,402 20,972 20,315 17,601 Malaysia 18,806 23,107 29,390 31,052 Vietnam2 N.A. N.A. N.A. 3,300 Total 39,208 44,079 49,705 51,953 NUMBER OF OUTPATIENT Singapore 277,398 308,308 288,638 252,071 Malaysia 166
Slide 17: Key Leverage Ratios
Confidential Key Leverage Ratios Jun 2022 Jun 2023 Dec 2023 Jun 2024 Jun 2024 S$’m (Actual) (Actual) (Actual) (Actual) (Proforma)(1) Total Debts 629.1 747.8 1,106.9 1,106.2 1,106.2 Cash (161.6) (286.6) (271.9) (167.3) (167.3) Net Debts 467.5 461.2 835.0 947.5 947.5 Equity 608.3 575.4 563.3 578.2 578
Slide 18: Future Growth Plans
4 Future Growth Plans Confidential 18
Slide 19: TMG Going Forward: Building for Long-Term Growth
Confidential TMG Going Forward: Building for Long-Term Growth • Strategic high-value healthcare markets high demand for premium healthcare services. • Markets offering high growth potential, capitalizing the Group’s established presence and expertise in Regional Singapore, Malaysia and Vietnam. Expa
Slide 20: Thank You!
THANK YOU! Thomson Medical Group Limited 101 Thomson Road #20-04/05 United Square Singapore 307591 Confidential 20